850554-39-1Relevant academic research and scientific papers
Preparation of iodine-123 labeled AM251: A potential spect radioligand for the brain cannabinoid CB1 receptor
Lan, Ruoxi,Gatley, S. John,Makriyannis, Alexandros
, p. 875 - 881 (1996)
We report the synthesis and labeling with iodine-123 of N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole -3-carboxamide (AM251). This compound is an anlog of the recently described cannabinoid receptor antagonist, R141716A,
NOVEL HETEROPYRROLE ANALOGS ACTING ON CANNABINIOD RECEPTORS
-
Page/Page column 60, (2008/06/13)
Disclosed are biologically active hetero pyrrole analogs such as imidazoles, thiazoles, oxazoles and pyrazoles capable of interacting with the CB1 and/or the CB2 cannabinoid receptors. One aspect discloses hetero pyrrole analogs acting as antagonists for
Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists
Lan, Ruoxi,Liu, Qian,Fan, Pusheng,Lin, Sonyuan,Fernando, Susanthi R.,McCallion, Deirdre,Pertwee, Roger,Makriyannis, Alexandras
, p. 769 - 776 (2007/10/03)
As a potent, specific antagonist for the brain cannabinoid receptor (CB1), the biarylpyrazole N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A; 1) was the lead compound for initiating studies desi
